Group B streptococcal (GBS) infection remains the most common cause of neonatal early-
onset sepsis and a signiicant cause of late-onset sepsis among young infants …

Background Maternal rectovaginal colonization with group B Streptococcus (GBS) is the
most common pathway for GBS disease in mother, fetus, and newborn. This article, the …

Summary Background Group B streptococcus (GBS) colonisation during pregnancy can
lead to invasive GBS disease (iGBS) in infants, including meningitis or sepsis, with a high …

Background Although meningitis is largely preventable, it still causes hundreds of thousands
of deaths globally each year. WHO set ambitious goals to reduce meningitis cases by 2030 …

Background We aimed to provide the first comprehensive estimates of the burden of group B
Streptococcus (GBS), including invasive disease in pregnant and postpartum women, fetal …

Abstract Background Group B Streptococcus (GBS) remains a leading cause of neonatal
sepsis in high-income contexts, despite declines due to intrapartum antibiotic prophylaxis …

Invasive disease due to group B Streptococcus infection (Streptococcus agalactiae) results
in a wide spectrum of clinical disease. In North America, serotypes Ia, Ib, II, III, and V are …

Background The incidence of neonatal sepsis in India is the highest in the world. Evidence
regarding its risk factors can guide clinical practice and prevention strategies. Objective To …

Background Preterm birth complications are the leading cause of deaths among children< 5
years of age. Studies have suggested that group B Streptococcus (GBS) maternal …

Abstract Altogether, 20–30% of women receive intrapartum antibiotic prophylaxis (IAP) to
prevent sepsis in infants and 2–5% of newborn infants receive antibiotics due to suspected …